Artrya Limited (AYA.AX)
AUD 0.47
(2.17%)
AUD 0.47
(2.17%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 13.24 Million | 552 Thousand | 202 Thousand | 38.51 Thousand | 11.54 Thousand | 90.00 |
| Gross Profit | -13.24 Million | -552 Thousand | -202 Thousand | -38.51 Thousand | -11.54 Thousand | -90.00 |
| Operating Expenses | 1.15 Million | 11.87 Million | 16.78 Million | 4.2 Million | 1.74 Million | 145.57 Thousand |
| Selling, General and Administrative Expenses | 972 Thousand | 11.89 Million | 10.68 Million | 4.2 Million | 1.74 Million | 145.57 Thousand |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 182 Thousand | 19 Thousand | 113 Thousand | - | - | - |
| Cost and Expenses | 14.4 Million | 12.42 Million | 16.78 Million | 4.23 Million | 1.75 Million | 145.66 Thousand |
| Operating Income | -14.4 Million | -12.42 Million | -16.61 Million | -4.23 Million | -1.75 Million | -145.66 Thousand |
| Interest Expense | 31 Thousand | 58 Thousand | 7000.00 | 26.74 Thousand | 6603.00 | 10.00 |
| Income Tax Expense | 27 Thousand | 18 Thousand | 535 Thousand | -5.00 | -4.00 | -171.77 Thousand |
| Earnings before Tax | -13.97 Million | -11.11 Million | -16.62 Million | -4.07 Million | -1.35 Million | -145.67 Thousand |
| Net Income | -14 Million | -11.13 Million | -17.15 Million | -4.08 Million | -1.35 Million | -145.67 Thousand |
| Earnings Per Share Basic | -0.18 | -0.14 | -0.26 | -0.12 | -0.06 | -0.00 |
| Earnings Per Share Diluted | -0.18 | -0.14 | -0.26 | -0.12 | -0.06 | -0.00 |
| Weighted Average Shares Outstanding | 78.64 Million | 78.36 Million | 66.17 Million | 34.43 Million | 22.33 Million | 78.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 78.64 Million | 78.38 Million | 66.17 Million | 34.43 Million | 22.33 Million | 78.11 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -13.95 Million | -10.5 Million | -16.39 Million | -4.01 Million | -1.33 Million | -145.57 Thousand |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 1.99 Million | 4851.50 | 4851.50 | 989 Thousand | 1771.50 | 301 Thousand |
| Gross Profit | -1.99 Million | -4851.50 | -4851.50 | -989 Thousand | -1771.50 | -301 Thousand |
| Operating Expenses | 16.05 Million | -1195.00 | -1195.00 | 7.92 Million | 1772.00 | 4.99 Million |
| Selling, General and Administrative Expenses | - | 166.50 | 166.50 | 7.92 Million | 652.50 | 5.01 Million |
| Research and Development Expenses | - | 1536.50 | 1536.50 | 1536.50 | 1536.50 | 1276.00 |
| Other Expenses | - | -2898.00 | -2898.00 | - | - | 19 Thousand |
| Cost and Expenses | 18.04 Million | 3656.50 | 3656.50 | 8.91 Million | 3543.50 | 5.29 Million |
| Operating Income | -18.04 Million | -3656.50 | -3656.50 | -8.91 Million | -3531.50 | -5.29 Million |
| Interest Expense | 31 Thousand | - | - | 35 Thousand | - | 31 Thousand |
| Income Tax Expense | 27 Thousand | 2.00 | 2.00 | 23 Thousand | 11.50 | 6000.00 |
| Earnings before Tax | -13.97 Million | -3558.50 | -3558.50 | -6.85 Million | -3428.00 | -4.67 Million |
| Net Income | -14 Million | -3.56 Million | -3.56 Million | -3.43 Million | -3.43 Million | -2.33 Million |
| Earnings Per Share Basic | - | -0.05 | -0.05 | -0.04 | -0.04 | -0.03 |
| Earnings Per Share Diluted | - | -0.05 | -0.05 | -0.04 | -0.04 | -0.03 |
| Weighted Average Shares Outstanding | 78.64 Million | 78.67 Million | 78.67 Million | 78.61 Million | 78.61 Million | 78.32 Million |
| Weighted Average Shares Outstanding (Diluted) | 78.64 Million | 78.67 Million | 78.67 Million | 78.61 Million | 78.61 Million | 78.41 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | - | -3546.75 | -3415.50 | -7.92 Million | -3037.00 | -4.99 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
NER
SPNS
BIOCQ
6H90
002181
HTCMF